Infectious Disease Reports, Volume 18, Issue 1
2026 February - 19 articles
Cover Story: Cutaneous leishmaniasis remains a major global health burden, with current therapies often limited by systemic toxicity and variable efficacy. Amphotericin B is a potent alternative, yet the need for intravenous administration restricts its clinical use. In this study, we developed and evaluated polymeric and lipid-based topical nanocarriers loaded with Amphotericin B to enhance local drug delivery and therapeutic outcomes. Using a murine model of Leishmania amazonensis infection, both formulations significantly reduced lesion progression and parasite burden at the infection site. These findings highlight the importance of formulation design and treatment timing, underscoring topical nanocarriers as promising strategies for safer, more effective management of cutaneous leishmaniasis. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.